US Stock MarketDetailed Quotes

TRML Tourmaline Bio

Watchlist
  • 13.760
  • -0.800-5.49%
Trading May 21 13:13 ET
352.90MMarket Cap-6644P/E (TTM)

About Tourmaline Bio Company

Tourmaline Bio, Inc. is a late-stage clinical biotechnology company, which engages in the development of medicines for patients with life-altering immune diseases. It offers the TOUR006. The company was founded by Sandeep Kulkarni on September 17, 2021 and is headquartered in New York, NY.

Company Profile

SymbolTRML
Company NameTourmaline Bio
Listing DateMay 7, 2021
Founded2021
CEODr. Sandeep C. Kulkarni, M.D.
MarketNASDAQ
Employees44
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address27 West 24th Street,Suite 702
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10010
Phone1-646-481-9832
Websitehttp://www.tourmalinebio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sandeep C. Kulkarni, M.D.
  • Chief Executive Officer and Director
  • 2.09M
  • Susan Dana Jones, PhD
  • Chief Technology Officer
  • --
  • Yung H. Chyung, M.D.
  • Executive Vice President and Chief Medical Officer
  • 764.67K
  • W. Bradford Middlekauff, J.D.
  • Chief Business Officer and General Counsel
  • --
  • Ryan F. Robinson
  • Vice President, Finance, Controller, Interim Chief Financial Officer and Principal Accounting Officer
  • --
  • Kevin Bruce Johnson, PhD
  • Chief Regulatory Officer
  • 569.95K
  • Dr. Clay B. Siegall,PhD
  • Chairman of the Board
  • 274.80K
  • Mark D. Mcdade
  • Independent Director
  • 238.30K
  • Aaron Kantoff
  • Independent Director
  • 79.51K
  • Parvinder Thiara
  • Independent Director
  • 77.51K
  • Dr. Sapna Srivastava, PhD
  • Independent Director
  • 246.90K
  • Dr. Caley Castelein, M.D.
  • Independent Director
  • 79.41K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg